Drug Shortage Update: Eptifibatide Injection

Eptifibatide Injection
September, 23 2015

Products Affected:
Integrilin injection, Merck
2 mg/mL, 10 mL vial, 1 count (NDC 00085-1177-01) 

Reason for the Shortage:
Merck cannot provide a reason for the shortage. 

Available Products:
Integrilin injection, Merck
0.75 mg/mL, 100 mL vial, 1 count (NDC 00085-1136-01)
2 mg/mL, 100 mL vial, 1 count (NDC 00085-1177-02) 

Estimated Resupply Dates:
Merck has Integrilin 2 mg/mL 10 mL vials on back order and the company cannot estimate a release date. 

Related Shortages:
Anagrelide Capsules - Resolved
Cilostazol Tablets  - Resolved
Ticlopidine Tablets - No Longer Available 

Updated
September 23, 2015, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT. 

Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug. - See more at: http://www.ashp.org/menu/DrugShortages/CurrentShortages/Bulletin.aspx?id=1210#sthash.zQ11DsU0.dpuf

Source: American Society of Health-System Pharmacists